Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
BILLERICA, Mass., April 01, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried blood spot extraction (DBS) kit as part of their industry-leading Simoa® assay kits at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD) in Vienna, Austria. This new extraction kit enables researchers to measure low-concentration biomarkers from dried blood spots using a more cost-effective and less invasive method.
Current Alzheimer's and neurodegenerative disease tests often require complex sample handling, repeated collections, and offer limited accessibility, particularly in remote or resource-limited settings, due to their reliance on venous blood draws. To address this, Quanterix, leveraging research from its collaboration with the DROP-AD Project at the University of Gothenburg, has developed a downstream DBS extraction kit that includes buffers and a sample preparation protocol, enabling accurate and sensitive measurement of neuro biomarkers from a DBS matrix. Validation studies show that DBS samples from two different devices tested with Simoa ALZpath p-Tau 217 and the Simoa extraction kit demonstrated correlation to venous in simulated CSF spiked samples of 0.75 to 0.86. This advancement lays critical groundwork for the development of scalable, minimally invasive diagnostic tools that can be deployed more broadly and equitably across populations.
"Our new dried blood spot (DBS) extraction kit represents a major step forward in making biomarker testing more accessible," said Masoud Toloue, PhD, Chief Executive Officer of Quanterix. "By simplifying sample collection, DBS has the potential to expand participation in Alzheimer's research and clinical trials—especially among under-represented populations. This advancement will deepen our ability to understand the disease and its progression across diverse communities."
Additionally, Quanterix's Simoa platform will be featured in over 80 posters, presentations, and sessions at AD/PD, demonstrating its significant role in advancing neurodegenerative disease research. For a full list of research available at AD/PD, please visit AD/PD's event website.
About Quanterix
From discovery to diagnostics, Quanterix's ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company's Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,200 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331774518/en/
Contacts
Media Contact:Marissa Klaassen(978) 488-1854media@quanterix.com
Investor Relations Contact:Joshua Young(508) 846-3327ir@quanterix.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
28 minutes ago
- Business Wire
Vitable Health Expands Care-Backed ICHRA Platform to Pennsylvania, Texas, and Florida Amid Rising Demand for SMB Health Benefits
PHILADELPHIA--(BUSINESS WIRE)-- Vitable Health, the leading all-in-one health benefits platform redefining care for the American workforce, today announced the availability of its care-backed ICHRA (Individual Coverage Health Reimbursement Arrangement) services in Pennsylvania, Texas, and Florida. This expansion follows the company's successful launch in Ohio and reflects growing demand from small businesses for health benefits that actually deliver care, not just coverage. As healthcare costs rise and small businesses continue to be left behind by traditional group insurance models, ICHRA adoption is accelerating across the country. New U.S. Census Bureau data, analyzed by BenefitsPro, shows that Florida and Texas are among the states with the highest uninsured rates, underscoring the urgent need for solutions that help employers close coverage gaps. According to the most recent HRA Council report, 83.5% of employers offering an ICHRA or QSEHRA did not provide any health benefits prior—a sign of the model's potential to expand access where it's needed most. 'Legislation will always lag behind reality,' said Joseph Kitonga, CEO of Vitable Health. 'This expansion is about more than geography, it's about proving that small businesses don't need to wait for lawmakers to fix the system. Affordable, high-quality healthcare for the working class isn't theoretical. It's here, it's working, and it's only the beginning.' In many of these markets, small businesses are facing what Vitable Health calls 'coverage deserts,' where traditional plans have become cost-prohibitive or inaccessible. By combining ICHRA administration with unlimited virtual primary care, preventive screenings, diagnostic lab panels, and zero-dollar prescriptions, Vitable removes the friction that typically keeps benefits and care siloed. This integrated model simplifies compliance for employers while improving health access and engagement for employees, particularly in industries like home health, construction, and hospitality, where coverage has historically been out of reach. In Pennsylvania, where Vitable Health is headquartered, this expansion marks the next stage of growth in the company's largest and most mature market. In Texas and Florida, two of the country's most challenging benefits environments, Vitable Health is helping employers deliver a competitive edge by pairing cost-efficient ICHRA benefits with real care. 'With Ohio's HB 133 and Indiana's HB 1004 setting the tone and ICHRA bills surfacing in other states, the message is clear: change is coming,' Kitonga added. 'The employers who act now aren't just getting ahead of the curve—they're leading it.' With this multi-state expansion, Vitable Health is demonstrating what a new standard for small-business health benefits looks like: affordable, accessible, and centered on real care rather than bureaucracy. To learn more about Vitable Health's ICHRA and primary care offerings for small businesses, visit Vitable Health is the nation's leading health benefits platform, making healthcare better for business owners and employees. With a focus on real access over red tape, Vitable Health offers employers affordable, ACA-compliant health benefit solutions, including Minimum Essential Coverage (MEC) plans, MVP plans, and ICHRA and QSEHRA options, that are packaged with Direct Primary Care and can be enhanced with Vision and Dental benefits. Every plan includes access to virtual primary care visits, mental health coaching, and over 1,000 covered prescriptions and labs with zero out-of-pocket costs. To date, Vitable Health has raised $25 million from top-tier investors, including First Round Capital, Y Combinator, Cherryrock Capital, Citi Bank's Impact Fund, Commerce Ventures, Jack Altman, Michael Seibel, Immad Akhund, and SoftBank Opportunity Fund.
Business Wire
28 minutes ago
- Business Wire
OnMed Named Among Top 7% of Fastest-Growing Companies in America
NEW YORK--(BUSINESS WIRE)--Inc., the leading media brand and playbook for entrepreneurs, announced today that OnMed is No. 337 in the annual Inc. 5000 list, placing the company in the top 7% of the fastest-growing private companies in America. As the demand for access to healthcare continues to exponentially grow, this honor recognizes OnMed as a fast-growing alternative to clinic-based care and telemedicine, which have both hit a ceiling from a sustainability standpoint. 'An incredible purpose, a high-performing team that's in it together, and laser-focused execution can move mountains,' said Karthik Ganesh, CEO of OnMed. 'We're grateful to be on this list but we're only getting started.' Share 'An incredible purpose, a high-performing team that's in it together, and laser-focused execution can move mountains,' said Karthik Ganesh, CEO of OnMed. 'We're grateful to be on this list but we're only getting started.' From its roots as a bold idea to reimagine healthcare delivery, OnMed now operates in seven states, with plans to play a central role in the healthcare solution envisioned by the One Big Beautiful Bill (OBBB). The company's patented CareStation, an 8' x 11' Clinic-in-a-Box combines the scalability of telehealth with the human approach and diagnostics of a clinic. Serving primary, urgent, and post-acute care in one secure, tech-enabled space, this is a new model for our public health infrastructure that delivers convenience, affordability, and a personal care experience. In a healthcare landscape often dominated by tech-for-tech's sake, wearables, and AI tools that fail to reach millions of underserved Americans, OnMed stands apart. Its vision is clear: everyday healthcare, everywhere. OnMed's purpose is singular, but powerful, to improve the quality of life and sense of wellbeing in communities by bringing timely care, where and when it is needed most. By partnering with public and private organizations; including payors, health systems, colleges, government agencies, and employers; and being deployed at places like grocery stores, homeless shelters, airports, prisons, and community centers; OnMed is bringing care to meet people seamlessly in their lives. 'This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market,' said Mike Hofman, editor-in-chief of Inc. 'They didn't just weather the storm—they grew through it.' For the full list of Inc. 5000 companies, visit: Inc. will celebrate the honorees at the 2025 Inc. 5000 Conference & Gala, taking place October 22–24 in Phoenix. About OnMed OnMed is the premier tech-enabled hybrid care company partnering with public and private organizations to reimagine healthcare access and improve health equity in communities across the country. With its patented 8' x 11' CareStations, OnMed combines the best elements of traditional primary, urgent, and post-acute care with the technology of telemedicine to deliver convenient, affordable care to underserved communities, anywhere they are. The company licenses its cutting-edge technology and care delivery model to a wide range of organizations, including governments, employers, colleges, healthcare provider systems, payors, and high- traffic venues. OnMed is paving the way for everyday healthcare, everywhere.
Business Wire
28 minutes ago
- Business Wire
TailorCare Appoints Kara Rios as Chief Financial Officer
NASHVILLE, Tenn.--(BUSINESS WIRE)-- TailorCare, a leading provider of specialty value-based care solutions for musculoskeletal health, announced today the appointment of Kara Rios as its Chief Financial Officer. Rios brings more than 25 years of financial and operational leadership experience in healthcare, technology, and high-growth startup environments. "Kara's leadership in both startup and large-scale healthcare organizations makes her uniquely equipped to guide TailorCare's next stage of growth." - Rachel Winokur, CEO TailorCare As CFO, Rios will oversee all aspects of TailorCare's financial operations, including accounting, budgeting, forecasting, risk management, and capital strategy. She will play a pivotal role in shaping the company's financial vision, optimizing value-based care cost structures, and capital-raising efforts. 'Kara's leadership in both startup and large-scale healthcare organizations makes her uniquely equipped to guide TailorCare's next stage of growth,' said Rachel Winokur, founder and CEO at TailorCare. 'Her strategic clarity and operational rigor will be critical as we expand access to high-quality, value-based care that improves patient pathways to joint, back, and muscle health.' Prior to joining TailorCare, Rios held CFO roles at Firefly Health, Harbor Health, Bright HealthCare, and UnitedHealthcare Community and State. Her leadership has consistently delivered strong results in operations, cost, and team development. She also served as President of UnitedHealth Group's Central Region Medicaid operations, where she led the expansion of service coverage and improved profitability during a period of complex regulatory changes. 'I'm honored to join TailorCare at such a transformational time in the company's growth,' said Rios. 'The commitment to compassionate healthcare and innovation deeply resonates with my values as a leader. I look forward to working alongside Rachel and the team to accelerate our mission and impact.' Rios earned her bachelor's degree in Accounting from the University of St. Thomas and currently resides in Edina, Minnesota. About TailorCare TailorCare is a leading specialty value-based care solution focused on improving patient outcomes for joint, back, and muscle conditions. We take a deeply personal, data-driven approach by carefully assessing patients' symptoms, health history, preferences, and goals. Utilizing predictive data and the latest evidence-based guidelines, we guide patients in choosing and navigating the most effective treatment pathways every step of the way. Learn more at and follow us on LinkedIn at @TailorCare.
